Biodesix's Series B Round

Biodesix raised a round of funding on September 21, 2009.

Biodesix is a fully integrated molecular diagnostics company advancing the development of products for personalized medicine. Biodesix developed, validated and commercialized VeriStrat, a serum proteo…

Articles about Biodesix's Series B Round: